Publications by authors named "V I Beliavskaia"

Article Synopsis
  • The study investigates somatic mutations of the p53 gene in stomach cancer patients, utilizing sequential and molecular cloning methods.
  • It identified a total of 8 mutations across different tumor types, including a notable single-nucleotide deletion that led to a shifted reading frame and several missense mutations resulting in amino acid changes.
  • The research highlights that all mutations appeared in crucial codons, supporting previous findings that tumors display diverse p53 genetic alterations.
View Article and Find Full Text PDF

This study involved 525 breast cancer (BC) patients of T2-4N0-2M0 stages at the age of 35 years and older. Significant differences in clinical and pathological characteristics between premenopausal and postmenopausal BC patients were found. Mostly marked differences were shown for positive lymph node correlation with distant metastasis, multicentric growth and local recurrence depending on menopause status.

View Article and Find Full Text PDF

The P53 protein is a key regulator of modified-cell apoptosis. The functional oligonucleotide polymorphism of the p53 gene causes the substitution of arginine (Arg) for praline (Pro) in the codon 72. A reduced apoptotic activity of p53 and, as a consequence, development of oncology pathology is associated with the above polymorphism.

View Article and Find Full Text PDF

The present review deals with the analysis of biological and functional activities of recombinant bacteria Bacillus subtilis IF-alpha 2335 are producing a human interferon. The interferon-producing bacteria are constructed on a basis commercial probiotic strain B.subtilis 2335, carrying a recombinant plasmid pMBM 105 with the gene of human alpha-2 interferon.

View Article and Find Full Text PDF

The characterization of known Salmonella vaccine strains and different attenuated mutants used for developing new vaccines is presented. The use of attenuated Salmonella strains as vaccine vector for the supply of heterologous antigens opens prospects for the creation of effective and commonly available vaccines which approximate the "ideal" vaccine in their qualitative characteristics. The possibility of the genetic modification of attenuated strains permits their targeted reconstruction, considering the specific features of the formation of immune response to the definite heterologous antigen supplied to the body by the bacterial vector.

View Article and Find Full Text PDF